Literature DB >> 19631301

Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?

Philippe Lesclous1, Semaan Abi Najm, Jean-Pierre Carrel, Brigitte Baroukh, Tommaso Lombardi, Jean-Pierre Willi, René Rizzoli, Jean-Louis Saffar, Jacky Samson.   

Abstract

Osteonecrosis of the jaw (ONJ) can be associated with nitrogen-containing bisphosphonates (NBPs) therapy. Various mechanisms of NBP-associated ONJ have been proposed and there is currently no consensus of the underlying pathogenesis. The detailed medical and dental histories of 30 ONJ patients treated with NBPs for malignant diseases (24) or osteoporosis (6) were analyzed. The necrotic bone was resected and analyzed histologically after demineralization. In 10 patients the perinecrotic bone was also resected and processed without demineralization. Alveolar bone samples from 5 healthy patients were used as controls. In 14 ONJ patients, serial technetium-99m-methylene diphosphonate scintigraphic scans were also available and confronted to the other data. Strong radionuclide uptake was detected in some patients several months before clinical diagnosis of ONJ. The medullary spaces of the necrotic bone were filled with bacterial aggregates. In the perinecrotic bone, the bacteria-free bone marrow characteristically showed an inflammatory reaction. The number of medullary inflammatory cells taken as an index of inflammation allowed us to discriminate two inflammation grades in the ONJ samples. Low-grade inflammation, characterized by marrow fibrosis and low inflammatory cells infiltration, increased numbers of TRAP(+) mono- and multineacleated cells was seen in patients with bone exposure<2 cm(2). High-grade inflammation, associated with larger lesions, showed amounts of tartrate-resistant acid phosphatase(+)/calcitonin receptor(-) mono- and multinucleated cells, osteocyte apoptosis, hypervascularization and high inflammatory cell infiltration. The clinical extent of ONJ was statistically linked to the numbers of inflammatory cell. Taken together these data suggest that bone necrosis precedes clinical onset and is an inflammation-associated process. We hypothesize that from an initial focus, bone damage spreads centrifugally, both deeper into the jaw and towards the mucosa before the oral bone exposure and the clinical diagnosis of ONJ.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631301     DOI: 10.1016/j.bone.2009.07.011

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  61 in total

Review 1.  The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing.

Authors:  Matthew R Allen
Journal:  Odontology       Date:  2011-01-27       Impact factor: 2.634

Review 2.  Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review.

Authors:  Cesar A Migliorati; Joel B Epstein; Elliot Abt; James R Berenson
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

3.  Antibiotic effects on bacterial profile in osteonecrosis of the jaw.

Authors:  X Ji; S Pushalkar; Y Li; R Glickman; K Fleisher; D Saxena
Journal:  Oral Dis       Date:  2011-08-29       Impact factor: 3.511

4.  Cutting edge: nitrogen bisphosphonate-induced inflammation is dependent upon mast cells and IL-1.

Authors:  John T Norton; Tomoko Hayashi; Brian Crain; John S Cho; Lloyd S Miller; Maripat Corr; Dennis A Carson
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

5.  Compressive force strengthened the pro-inflammatory effect of zoledronic acid on il-1ß stimulated human periodontal fibroblasts.

Authors:  Sarah Grimm; Ambili Mundethu; Judit Symmank; Christoph Hennig; Christian Walter; Elisabeth Reichardt; Heiner Wehrbein; Collin Jacobs
Journal:  Clin Oral Investig       Date:  2020-11-09       Impact factor: 3.573

Review 6.  Osteonecrosis of the Jaw-a Bone Site-Specific Effect of Bisphosphonates.

Authors:  Jenny A F Vermeer; Greetje A P Renders; Vincent Everts
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

7.  The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy.

Authors:  Satish K S Kumar; Amita Gorur; Christoph Schaudinn; Charles F Shuler; J William Costerton; Parish P Sedghizadeh
Journal:  Curr Osteoporos Rep       Date:  2010-03       Impact factor: 5.096

Review 8.  The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of "phossy" and "bisphossy" jaw.

Authors:  C Jacobsen; W Zemann; J A Obwegeser; K W Grätz; P Metzler
Journal:  Oral Maxillofac Surg       Date:  2012-12-28

9.  Osteo-radio-necrosis (ORN) and bisphosphonate-related osteonecrosis of the jaws (BRONJ): the histopathological differences under the clinical similarities.

Authors:  Konstantinos T Mitsimponas; Patrick Moebius; Kerstin Amann; Philipp Stockmann; Karl-Andreas Schlegel; Friedrich-Wilhelm Neukam; Falk Wehrhan
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

10.  Relevance of surgical management of patients affected by bisphosphonate-associated osteonecrosis of the jaws. A prospective clinical and radiological study.

Authors:  Philippe Lesclous; Sophie Grabar; Semaan Abi Najm; Jean-Pierre Carrel; Tommaso Lombardi; Jean-Louis Saffar; Jacky Samson
Journal:  Clin Oral Investig       Date:  2013-04-19       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.